Table 2. Clinical character.
| Group (n) | with ATX (26) | without ATX (202) | p value |
|---|---|---|---|
| Gender (men/women) | 23/3 | 157/45 | |
| Age of the first onset of ACS (y) | 62 ± 15 | 65 ± 13 | 0.35 |
| SBP (mmHg) | 136 ± 26 | 138 ± 26 | 0.65 |
| DBP (mmHg) | 77 ± 17 | 79 ± 17 | 0.37 |
| BMI | 26.1 ± 4.0 | 24.0 ± 3.5 | < 0.01* |
| Plasma glucose (mg/dl) | 189 ± 99 | 160 ± 71 | 0.34 |
| HbA1c (%) | 7.1 ± 1.8 | 6.3 ± 1.3 | < 0.01* |
| Hypertension (%) | 19 (73.1) | 146 (72.2) | 0.84 |
| Family history of CHD (%) | 11 (42.3) | 67 (33.1) | 0.38 |
| Smoking (none/past/current) | 6/9/11 | 55/66/81 | 0.91 |
| Pre-treatment with statin (%) | 10 (38.5) | 55 (27.2) | 0.43 |
| ACS (STEMI/NSTEMI/recent MI/UA) | 15/2/2/7 | 126/24/15/37 |
Data were shown as mean ± SD.
*
by Wilcoxon runk sum test
ATX = Achilles tendon xanthoma, STEMI = ST-segment elevation myocardial infarction, NSTEMI = non–ST-segment elevation myocardial infarction, recent MI = recent myocardial infarction, UA = Unstable angina